Myocardial infarction marker levels are influenced by prothrombin and tumor necrosis factor-α gene polymorphisms in young patients

Doughty, 2002, Acute myocardial infarction in the young. The University of Michigan experience, Am Heart J, 143, 56, 10.1067/mhj.2002.120300 Zimmerman, 1995, Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry), J Am Coll Cardiol, 26, 654, 10.1016/0735-1097(95)00254-2 Williams, 1998, Myocardial infarction in young people with normal coronary arteries, Heart, 79, 191, 10.1136/hrt.79.2.191 Zdravkovic, 2007, Genetic susceptibility of myocardial infarction, Twin Res Hum Genet, 10, 848, 10.1375/twin.10.6.848 Hansson, 2005, Inflammation, atherosclerosis, and coronary artery disease, N Engl J Med, 352, 1685, 10.1056/NEJMra043430 Ozaki, 2006, A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population, Nat Genet, 38, 921, 10.1038/ng1846 Hubacek, 1999, C(-260) → T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction, Circulation, 99, 3218, 10.1161/01.CIR.99.25.3218 Georges, 2001, Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l’Infarctus du Myocarde, J Mol Med, 79, 300, 10.1007/s001090100209 Um, 2003, Association of interleukin-1 alpha gene polymorphism with cerebral infarction, Brain Res Mol Brain Res, 115, 50, 10.1016/S0169-328X(03)00179-7 Bernard, 2003, The −308G/A tumor necrosis factor-alpha gene dimorphism: a risk factor for unstable angina, Clin Chem Lab Med, 41, 511, 10.1515/CCLM.2003.077 Gretarsdottir, 2003, The gene encoding phosphodiesterase 4D confers risk of ischemic stroke, Nat Genet, 35, 131, 10.1038/ng1245 Banerjee, 2008, Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population, Brain Res Bull, 75, 158, 10.1016/j.brainresbull.2007.08.007 Lio, 2004, Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease, J Med Genet, 41, 790, 10.1136/jmg.2004.019885 Licastro, 2007, Acute myocardial infarction and proinflammatory, Gene Variants Ann NY Acad Sci, 1119, 227, 10.1196/annals.1404.004 Lio, 2001, A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity, Hum Immunol, 62, 705, 10.1016/S0198-8859(01)00264-6 Scola, 2003, IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy, Mech Ageing Dev, 124, 569, 10.1016/S0047-6374(03)00038-1 Giacconi, 2008, Pro-inflammatory genetic background and zinc status in old atherosclerotic subjects, Ageing Res Rev, 7, 306, 10.1016/j.arr.2008.06.001 Forte, 2009, Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever, Clin Vaccine Immunol, 16, 811, 10.1128/CVI.00121-09 Wilson, 2003, Typing of tumor necrosis factor alleles, Methods Mol Biol, 210, 297 Wilson, 1997, Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation, Proc Natl Acad Sci USA, 94, 3195, 10.1073/pnas.94.7.3195 Allen, 1999, Polymorphism of the human TNF-alpha promoter-random variation or functional diversity, Mol Immunol, 36, 1017, 10.1016/S0161-5890(99)00127-3 Plutzky, 2001, Inflammatory pathways in atherosclerosis and acute coronary syndromes, Am J Cardiol, 88, 10, 10.1016/S0002-9149(01)01924-5 Zhang, 2011, Tumor necrosis factor-alpha G −308A gene polymorphism and coronary heart disease susceptibility: an updated meta-analysis, Thromb Res, 127, 400, 10.1016/j.thromres.2010.12.018 Mannucci, 2010, The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease, J Thromb Haemost, 8, 2116, 10.1111/j.1538-7836.2010.03982.x Ye, 2006, Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls, Lancet, 367, 651, 10.1016/S0140-6736(06)68263-9 Burzotta, 2004, G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome, Haematologica, 89, 1134 Incalcaterra, 2004, Genetic risk factors in myocardial infarction at young age, Minerva Cardioangiol, 52, 287 Burzotta, 2004, G20210A prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12,034 subjects, Heart, 90, 82, 10.1136/heart.90.1.82 Poort, 1996, A common genetic variation in the 3′-Untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood, 88, 3698, 10.1182/blood.V88.10.3698.bloodjournal88103698 Alhenc-Gelas, 1999, Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes, Thromb Haemost, 81, 506, 10.1055/s-0037-1614514 Rosendaal, 1998, Geographic distribution of the 20210G to A prothrombin variant, Thromb Haemost, 79, 706, 10.1055/s-0037-1615049 Arruda, 1997, Prevalence of the prothrombin gene variant (nt 20210A) in venous thrombosis and arterial disease, Thromb Haemost, 78, 1430, 10.1055/s-0038-1665428 Peetz, 2006, Method comparison of cardiac marker assays on PATHFAST, Stratus CS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader, Clin Lab, 52, 605 Lippi, 2007, Risk management in the preanalytical phase of laboratory testing, Clin Chem Lab Med, 45, 720, 10.1515/CCLM.2007.167 Galbraith, 1995, Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata, Hum Genet, 96, 433, 10.1007/BF00191802 Vaccarino, 2011, Role of prothrombotic polymorphisms in successful or unsuccessful aging, Biogerontology, 12, 445, 10.1007/s10522-011-9328-5 Miller, 1996, Increased activation of the hemostatic system in men at high risk of fatal coronary heart disease, Thromb Haemost, 75, 767, 10.1055/s-0038-1650364 Franco, 1999, The 20210GA mutation in the 3′ untranslated region of the prothrombin gene and the risk for arterial thrombotic disease, Br J Haematol, 104, 50, 10.1046/j.1365-2141.1999.01149.x Watzke, 1997, Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease, Thromb Res, 87, 521, 10.1016/S0049-3848(97)00181-3 Ridker, 1999, G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men, Circulation, 99, 999, 10.1161/01.CIR.99.8.999 Cavallini, 2005, Eur Heart J, 26, 1494, 10.1093/eurheartj/ehi173 Danesh, 2000, Haematocrit, viscosity, erythrocyte sedimentation rate: metaanalyses of prospective studies of coronary heart disease, Eur Heart J, 21, 515, 10.1053/euhj.1999.1699 Lowe, 1995, Fibrinogen and cardiovascular disease: historical introduction, Eur Heart J, 16, 2, 10.1093/eurheartj/16.suppl_A.2 Hashmi, 1969, Fibrinogen levels in patients suffering from acute myocardial infarction, J Atheroscler Res, 10, 277, 10.1016/S0368-1319(69)80016-5 Tatli, 2009, Plasma fibrinogen level may predict critical coronary artery stenosis in young adults with myocardial infarction, Cardiol J, 16, 317